COVID-19
Research conducted by the University of Utrecht's Julius Center for Health Sciences and Primary Care has found that preexisting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provide some protection against infection with the Omicron BA.1/BA.2 variant, but have no significant effect on symptom
COVID-19
Molnupiravir and nirmatrelvir/ritonavir combination therapy has been found to be safe and well-tolerated in a Phase I de-escalation trial for treating mild to moderate COVID-19. The trial, AGILE CST-8 (NCT04746183), evaluated the combination therapy in adult out-patients with SARS-CoV-2 infection. The results showed that no participant starting with the
COVID-19
A recent study published on biorxiv.org has made a significant discovery in the fight against SARS-CoV-2, the virus responsible for COVID-19. The research reveals that heparin, a long linear polysaccharide, has been identified as a promising drug target due to its crucial role in viral infection. However, its anticoagulant
COVID-19
A recent study has shed light on the effects of the COVID-19 pandemic on Epstein-Barr virus (EBV) seroprevalence in a French university hospital over an 11-year period. Researchers from Centre Hospitalier Universitaire Amiens Picardie analyzed data from 19,771 EBV serologies performed between January 2013 and December 2023. The study
Pediatrics
Researchers at Children's Hospital have developed symptom-based predictive models for early diagnosis of pediatric respiratory viral infections, including those caused by SARS-CoV-2, RSV, and influenza viruses. The study aims to expedite diagnoses in primary care settings, particularly for common pediatric respiratory viruses. The models demonstrated notable accuracy for
Pediatrics
Dengue fever, caused by the DENV virus, affects nearly half of the world's population, posing a significant global health challenge. Despite advances in vaccine development, significant challenges remain, including the need to avoid Antibody-Dependent Enhancement (ADE) and improve protection against all four serotypes of the virus. Recent reviews
Pediatrics
A new multiplex fluorescent PCR (polymerase chain reaction) method has been developed and evaluated for the simultaneous detection of six fastidious bacteria associated with respiratory tract infections in children. The study, conducted by Jingchao Shi and colleagues from Zhejiang University School of Medicine, utilized a SYBR Green-based multiplex fluorescent PCR
Infection
Public health in Rwanda is facing a critical threat from antimicrobial resistance (AMR), a natural process accelerated by human activity, mainly the misuse and overuse of antimicrobials. In 2019, an estimated 2,400 deaths were directly linked to drug-resistant infections, and another 9,800 were associated with them. The World
COVID-19
A recent patent application has revealed a novel combination therapy for treating COVID-19, utilizing a mix of natural supplements and medications. The therapy, designed by inventors Abdelhalim, Shaimaa Mahmoud Nashat Sayed and Gamaleldin, Mohamed Medhat Abdelwahab, aims to boost the immune system and reduce mortality rates among infected patients. The
COVID-19
Researchers from Thomas Jefferson University have made a significant discovery linking COVID-19 infection to the development of Parkinson's disease. The study, which was funded by the National Institutes of Health, investigated the relationship between viral infection and Parkinsonian pathology in mice. The findings suggest that infection with the
COVID-19
Two severe cases of paediatric COVID-19 infection have been reported in Hong Kong, highlighting the importance of vaccination and public health measures to prevent severe complications and death from the virus. The Centre for Health Protection (CHP) of the Department of Health has urged the public to take necessary precautions,
Gram-negative bacterial infections
Rising incidence of hospital-acquired infections caused by carbapenem-resistant gram-negative bacteria (CRGNB) threatens patient safety worldwide. A recent study conducted at Erciyes University Hospital in Kayseri, Turkey, aimed to identify risk factors and mortality rates associated with CRGNB infections in intensive care units. The study found that colonization, previous use of
